We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 2,117 results
  1. Biopharmaceutical Landscape

    This chapter traces the rapidly expanding clinical-develo** and market-approved biopharmaceutical portfolio. Although biological medicines have...
    Chapter 2023
  2. Innovations in the Cyanobacteria-Based Biorefineries for Biopharmaceutical Industries

    The biopharmaceutical industry witnesses exceptional growth globally since their emergence. It revitalizes our ability to combat antimicrobial...
    Ayesha Shahid, Fahad Khan, Muhammad Farooq in Pharmaceutical and Nutraceutical Potential of Cyanobacteria
    Chapter 2024
  3. Biopharmaceutical Critical Quality Attributes

    Manufacturers must ensure that the quality of their medicines, both for the drug substance (DS) and for the drug product (DP), meet all of the...
    Chapter 2023
  4. Manufacturing the Biopharmaceutical Drug Product

    Manufacture of the finished drug product is the last process step (from starting materials to drug substance and now to drug product) for the...
    Chapter 2023
  5. Downstream Purification of the Biopharmaceutical Drug Substance

    The upstream production process has been designed to yield the intended biopharmaceutical. But the upstream design carries with it a complex impurity...
    Chapter 2023
  6. The Challenge of Demonstrating Biopharmaceutical Product Comparability

    Manufacturers need the freedom to make changes for improving their biopharmaceutical processes, not only during clinical development, but also for...
    Chapter 2023
  7. Upstream Production of the Biopharmaceutical Drug Substance

    Upstream production of the biopharmaceutical drug substance involves living cells – whether it is living recombinant cells that express a recombinant...
    Chapter 2023
  8. Starting Materials for Manufacturing the Biopharmaceutical Drug Substance

    Starting materials (also referred to as source materials) are the starting point for cGMP manufacturing of the biopharmaceutical drug substance. Some...
    Chapter 2023
  9. Mammalian Cell Culture: An Edge to Biopharmaceutical Industry

    The future of mammalian cell culture is bright; thus, it is expanding. Many challenges remain, and new opportunities will emerge. This chapter...
    Priyancka Arora, Vaishnavi Singh, Ajay Kumar in Biomanufacturing for Sustainable Production of Biomolecules
    Chapter 2023
  10. Comparative analysis of drug-salt-polymer interactions by experiment and molecular simulation improves biopharmaceutical performance

    The propensity of poorly water-soluble drugs to aggregate at supersaturation impedes their bioavailability. Supersaturated amorphous...

    Sumit Mukesh, Goutam Mukherjee, ... Rebecca C. Wade in Communications Chemistry
    Article Open access 25 September 2023
  11. Cyclodextrin Based Host-Guest Inclusion Complex, an Approach to Enhancing the Physicochemical and Biopharmaceutical Application of Poorly Water-soluble Drugs

    H ost-guest inclusion complexes have been extensively studied for drug delivery applications. The host molecule, typically cyclodextrin, creates a...

    Muhammad Inam, Moshirian-Farahi Sareh Sadat, Wenjie Chen in Chemical Research in Chinese Universities
    Article 14 October 2023
  12. The Art of Setting Biopharmaceutical Specifications – Release and Shelf-Life

    Quality Control testing, coupled with the control over the manufacturing process, provides assurance of a biopharmaceutical’s identity, purity,...
    Chapter 2023
  13. Models Used for Biopharmaceutical Evaluation of Nanoparticulate Drug Delivery System (NPDDS)

    Nanoparticle drug delivery systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic...
    Chapter 2022
  14. An Empirical Analysis of Sacha Inchi (Plantae: Plukenetia volubilis L.) Seed Proteins and Their Applications in the Food and Biopharmaceutical Industries

    Sacha Inchi ( Plukenetia volubilis L.) is a plant native in the Amazon rainforest in South America known for its edible seeds, which are rich in...

    Mohammad Harun Ur Rashid, Erica Kok Jia Yi, ... Mohd Nazri Ismail in Applied Biochemistry and Biotechnology
    Article 18 November 2023
  15. Biopharmaceutical applications of Opuntia ficus-indica: bibliometric map, bioactivities and extraction techniques

    Opuntia ficus - indica (OFI), widely recognized as prickly pear, is a native species from Mexico, being also widely distributed in many other...

    Beatriz N. Guedes, Faezeh Fathi, ... Eliana B. Souto in European Food Research and Technology
    Article Open access 04 July 2023
  16. Spray dried mebendazole–loaded Soluplus-based polymeric micelles for improved biopharmaceutical attributes: in vitro and in vivo studies

    The aim of this research was to investigate spray-dried mebendazole (MBZ)–loaded Soluplus-based polymeric micelles (MBZ@PMs) for improved solubility...

    Tania Bajaj, Ghanshyam Das Gupta, Charan Singh in Colloid and Polymer Science
    Article 06 April 2024
  17. Aliivibrio fischeri L-Asparaginase production by engineered Bacillus subtilis: a potential new biopharmaceutical

    l -Asparaginase ( l -ASNase) is an enzyme applied in the treatment of lymphoid malignancies. However, an innovative l -ASNase with high yield and lower...

    Heitor B. S. Bento, Gabriela B. Paiva, ... Valéria C. Santos-Ebinuma in Bioprocess and Biosystems Engineering
    Article 16 August 2022
  18. Automated ion exchange chromatography screening combined with in silico multifactorial simulation for efficient method development and purification of biopharmaceutical targets

    Bioprocess development of increasingly challenging therapeutics and vaccines requires a commensurate level of analytical innovation to deliver...

    Gioacchino Luca Losacco, Michael B. Hicks, ... Erik L. Regalado in Analytical and Bioanalytical Chemistry
    Article 20 April 2022
  19. Capillary Electrophoresis–Mass Spectrometry (CE-MS) by Sheath–Flow Nanospray Interface and Its Use in Biopharmaceutical Applications

    Both capillary electrophoresis (CE) and mass spectrometry (MS) technologies are powerful analytical tools that have been used extensively in the...
    Mei Han, Richard Smith, Dan A. Rock in Capillary Electrophoresis-Mass Spectrometry
    Protocol 2022
  20. Ever-Present Threat of Adventitious Agent Contamination

    If there is one serious patient safety concern that permeates every aspect of biopharmaceutical manufacturing, it is the ever-present threat of...
    Chapter 2023
Did you find what you were looking for? Share feedback.